Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

753958

	registered interest
	date	19/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.
	tabling member printed	Lord Mendelsohn
	uin	HL1104
	answer	answer is ministerial correction date of answer 31/07/2017 answer text <p>The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone’s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.</p> answering member printed Lord O'Shaughnessy question first answered 31/07/2017 13:38:56 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

753959

	registered interest
	date	19/07/2017
	answering body	Department for Exiting the European Union
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government what terms they are seeking to agree with the European Union to ensure that no additional delays or restrictions are placed on imports of molybdenum-99 to the UK following the UK's departure from Euratom.
	tabling member printed	Lord Mendelsohn
	uin	HL1105
	answer	answer is ministerial correction date of answer 02/08/2017 answer text <p>The UK’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom.</p><p>The import or export of medical radioisotopes, including molybdenum-99 is not subject to any Euratom licensing requirements.These isotopes are governed and regulated under the Euratom framework; however, Euratom places no restrictions on the export of medical isotopes to countries outside the EU.</p><p>It is in everyone’s interest to not disrupt the timely access of treatment to patients; and to ensure that cross-border trade with the EU and Euratom is as frictionless as possible.</p><p> </p> answering member printed Baroness Anelay of St Johns question first answered 02/08/2017 14:39:06 answering member 3474 label Biography information for Baroness Anelay of St Johns
	tabling member	4286 label Biography information for Lord Mendelsohn

984272

	registered interest
	date	09/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what progress has been made to secure trade agreements to ensure the security of supply of medical radioisotopes following Brexit.
	tabling member printed	Baroness Golding
	uin	HL10480
	answer	answer is ministerial correction date of answer 17/10/2018 answer text <p>The United Kingdom already has robust, domestic regimes in place for the safety, security, transport, use and disposal of nuclear and radioactive materials – including medical radioisotopes – throughout their lifecycle. These regimes will remain in place when Euratom arrangements no longer apply in the UK, ensuring we exit with certainty, clarity and control.</p><p>The Government is continuing to prepare for all European Union exit scenarios and is confident that we will be able to continue to provide a seamless supply of medicines, including medical radioisotopes, to National Health Service patients from the moment we leave the EU.</p> answering member printed Lord O'Shaughnessy question first answered 17/10/2018 15:28:41 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	281 label Biography information for Baroness Golding

829014

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that the UK radiopharmaceutical supply after leaving Euratom might be relied upon to not have an impact on patients, in terms of (1) timeliness of delivery, and (2) the quantity supplied of radiopharmaceutical supplies produced (a) in the EU, and (b) outside the EU.
	tabling member printed	Lord Carlile of Berriew
	uin	HL4999
	answer	answer is ministerial correction date of answer 01/02/2018 answer text <p>The Government is fully aware of the importance of medical radioisotopes and the reliance on nuclear medicine for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in the interest of both the UK and European Union to avoid disruption in the timely access of treatment to patients; and to ensure that cross-border trade with the EU is frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 01/02/2018 15:22:50 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1138 label Biography information for Lord Carlile of Berriew